DiaSorin stock trades 1.99 percent below its yearly high

DiaSorin stock was trading at EUR 78.78 on Euronext Milan on September 28, 2026, at 11:23 a.m. CEST, 1.99 percent below its 52-week high of EUR 80.38. The latest investor debate combines a higher broker target with a recent move out of Italy's flagship index.

Barclays raises target to EUR 70.00

According to Teleborsa on September 8, 2026, Barclays lifted its DiaSorin price target from EUR 60.00 to EUR 70.00 while retaining an Underweight rating. The revised target remains EUR 8.78 below the intraday price of EUR 78.78, putting the broker view below the market quotation.

Q2 returns to growth

DiaSorin's operating trend improved during the second quarter. Yahoo Finance reports that H1 2026 revenue reached EUR 602.0 million, flat at constant exchange rates compared with H1 2025 and down 3 percent at current exchange rates. Q2 revenue grew 4 percent at constant exchange rates and 3 percent at current exchange rates, while adjusted EBITDA for the first half was EUR 194.0 million, down 7 percent at constant exchange rates.

The margin picture adds an important counterweight to the revenue recovery. The same transcript puts H1 adjusted EBITDA margin at 32 percent and says the Q2 margin improved to 33 percent from 31 percent in Q1, while full-year adjusted EBITDA margin guidance remained 32 percent to 33 percent.

Index status changes

Borsa Italiana reported on September 3, 2026, that Technoprobe would replace DiaSorin in the FTSE MIB from September 21, 2026, with DiaSorin moving to the FTSE Italia Mid Cap. That change alters the stock's index setting, but the market value remains EUR 3.9 billion as of September 28, 2026.

Stock stays near yearly high

DiaSorin's EUR 78.78 intraday price remains 1.99 percent below the EUR 80.38 52-week high, while the session range runs from EUR 78.40 to EUR 79.50 and volume stands at 43,832 shares.